Biodyne Co., Ltd.

KOSDAQ:A314930 Stock Report

Market Cap: ₩525.9b

Biodyne Valuation

Is A314930 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A314930 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A314930 (₩17670) is trading above our estimate of fair value (₩15831.76)

Significantly Below Fair Value: A314930 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A314930?

Key metric: As A314930 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for A314930. This is calculated by dividing A314930's market cap by their current book value.
What is A314930's PB Ratio?
PB Ratio12.2x
Book₩43.14b
Market Cap₩525.93b

Price to Book Ratio vs Peers

How does A314930's PB Ratio compare to its peers?

The above table shows the PB ratio for A314930 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average1.8x
A145720 Dentium
1x13.8%₩482.9b
A099190 i-SENS
1.8x62.9%₩529.5b
A336570 WON TECHLtd
3.5x46.6%₩399.8b
A041830 InBodyLtd
1.1x15.5%₩291.8b
A314930 Biodyne
12.2x63.4%₩525.9b

Price-To-Book vs Peers: A314930 is expensive based on its Price-To-Book Ratio (12.2x) compared to the peer average (1.8x).

Price to Book Ratio vs Industry

How does A314930's PB Ratio compare vs other companies in the KR Medical Equipment Industry?

3 CompaniesPrice / BookEstimated GrowthMarket Cap
A950130 Access Bio
0.3xn/aUS$134.85m
A008490 Suheung
0.3x9.1%US$105.73m
A083550 KM
0.3xn/aUS$24.61m
No more companies available in this PB range
A314930 12.2xIndustry Avg. 1.2xNo. of Companies15PB01.63.24.86.48+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: A314930 is expensive based on its Price-To-Book Ratio (12.2x) compared to the KR Medical Equipment industry average (1.2x).

Price to Book Ratio vs Fair Ratio

What is A314930's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A314930 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio12.2x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate A314930's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ray

₩100.3b

RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry.

A228670

₩6,470.00

7D

-0.3%

1Y

-73.4%

Vieworks

₩200.2b

Develops, manufactures, and sells imaging systems and solutions.

A100120

₩21,800.00

7D

6.3%

1Y

-19.1%

Boditech Med

₩347.2b

Offers instruments and diagnostic reagents in South Korea and internationally.

A206640

₩15,800.00

7D

0.1%

1Y

-10.4%